Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Influenza AInfluenza B
Interventions
DEVICE

Respirio Flu Test

The Respirio Flu Test is a rapid test for the detection of influenza A or influenza B in nasal secretions. The Respirio Flu Test is designed to be simple to use and generates a result within 20 minutes.

DEVICE

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a molecular diagnostic technique for the detection and identification of influenza viruses, both for clinical samples and isolates. The reverse-transcriptase polymerase chain reaction (RT-PCR) allows template viral RNA to be reverse transcribed producing complementary DNA (cDNA) which can then be amplified and detected.

DEVICE

Sofia® Influenza A+B Fluorescent Immunoassay (FIA)

Sofia® Influenza A+B Fluorescent Immunoassay (FIA) employs immunofluorescence to detect influenza A and influenza B viral nucleoprotein antigens in nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash samples taken directly from symptomatic patients.

Trial Locations (4)

4068

Taringa 7 Day Medical Practice, Brisbane

4075

Graceville Medical, Brisbane

4077

Inala Primary Care, Brisbane

4305

Limestone Medical Centre, Ipswich

All Listed Sponsors
lead

Ellume Pty Ltd

INDUSTRY

NCT02487173 - Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B | Biotech Hunter | Biotech Hunter